MAXTRA (Chlorpheniramine Maleate (2mg/5ml) + Phenylephrine (5mg/5ml))

Maxtra Syrup is a medicinal formulation intended for alleviating symptoms associated with the common cold in pediatric patients. It effectively addresses discomfort arising from nasal congestion, runny noses, and sneezing, facilitating easier breathing and overall comfort for children. The administration of Maxtra Syrup can be done with or without food; however, it is essential to adhere strictly to the dosing and duration as prescribed by a healthcare professional. The required dosage is contingent on factors such as the child’s age, weight, and the intensity of their symptoms. It is crucial to continue the medication for the full duration recommended by the healthcare provider, even if the child appears to show improvement before completing the course. Potential side effects may emerge, including nausea, vomiting, and headaches; these are generally mild and resolve on their own. If any unusual reactions are observed or if you have concerns regarding your child’s response to the treatment, seek medical advice promptly. Additionally, be aware that Maxtra Syrup may lead to drowsiness, so it is advisable not to engage the child in activities necessitating alertness until the effects of the medication are fully understood. Ensure that your child remains adequately hydrated during the course of treatment. It is vital to inform the healthcare provider if there are any pre-existing liver or kidney issues, as this may necessitate an adjustment in dosage. Please note that according to guidelines from health authorities, Maxtra Syrup is not recommended for children under the age of 4.